Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant mean » significant main (Expand Search), significant green (Expand Search), significant gap (Expand Search)
Showing 1,441 - 1,460 results of 21,342 for search '(( significant decrease decrease ) OR ( significant mean decrease ))*', query time: 0.43s Refine Results
  1. 1441
    Kaplan-Meier curve of the primary outcome.

    Kaplan-Meier curve of the primary outcome. by Karl Ingard (22582091)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 1442
    Number of Patients Who Reached the Primary and Secondary Endpoints During Follow-up.

    Number of Patients Who Reached the Primary and Secondary Endpoints During Follow-up. by Karl Ingard (22582091)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 1443
    Excluded studies with reasons for exclusion.

    Excluded studies with reasons for exclusion. by Si He (3236646)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 1444
    Subgroup Analysis of the Occurrence of the Primary Endpoint and Its Components.

    Subgroup Analysis of the Occurrence of the Primary Endpoint and Its Components. by Karl Ingard (22582091)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 1445
    Flow diagram of the studies included in the meta-analysis.

    Flow diagram of the studies included in the meta-analysis. by Si He (3236646)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 1446
    Cinnamaldehyde repellency test within 6 hours in parthenogenesis <i>H. longicornis.</i>

    Cinnamaldehyde repellency test within 6 hours in parthenogenesis <i>H. longicornis.</i> by Ceyan Kuang (8554557)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 1447
    Shares of antibiotic substances on total prescription in UTI treatment (N39.0, N30.0) by sex and age group in 2019 (female: n = 238.670 prescriptions; male: n = 40.641 prescriptions).

    Shares of antibiotic substances on total prescription in UTI treatment (N39.0, N30.0) by sex and age group in 2019 (female: n = 238.670 prescriptions; male: n = 40.641 prescription... by Thomas Hanslmeier (19949694)

    Published 2024
    Subjects: “…fluoroquinolone shares decreased…”
    Save to List
    Saved in:
  8. 1448
    Shares of antibiotic substances on total prescription by quarter from 2013 to 2019 for female and male patients with UTI (N39.0, N30.0)(female: n = 1.681.255 prescriptions; male: n = 269.151prescriptions).

    Shares of antibiotic substances on total prescription by quarter from 2013 to 2019 for female and male patients with UTI (N39.0, N30.0)(female: n = 1.681.255 prescriptions; male: n... by Thomas Hanslmeier (19949694)

    Published 2024
    Subjects: “…fluoroquinolone shares decreased…”
    Save to List
    Saved in:
  9. 1449
    Shares of specialist groups prescribing 1<sup>st</sup>, 2<sup>nd</sup>, and 3<sup>rd</sup> antibiotic prescriptions in UTI treatment of females (N39.0, N30.0) in 2018 and 2019.

    Shares of specialist groups prescribing 1<sup>st</sup>, 2<sup>nd</sup>, and 3<sup>rd</sup> antibiotic prescriptions in UTI treatment of females (N39.0, N30.0) in 2018 and 2019. by Thomas Hanslmeier (19949694)

    Published 2024
    Subjects: “…fluoroquinolone shares decreased…”
    Save to List
    Saved in:
  10. 1450
    Number of antibiotic prescriptions in female and male patients with UTI (N30.0 and/or N39.0).

    Number of antibiotic prescriptions in female and male patients with UTI (N30.0 and/or N39.0). by Thomas Hanslmeier (19949694)

    Published 2024
    Subjects: “…fluoroquinolone shares decreased…”
    Save to List
    Saved in:
  11. 1451
    Shares of antibiotic substances on total prescription in female patients with UTI (N39.0, N30.0) by physician specialties (GPs: n = 1.299.641 prescriptions; gynecologists n = 141.814 prescriptions; urologists n = 182.100 prescriptions).

    Shares of antibiotic substances on total prescription in female patients with UTI (N39.0, N30.0) by physician specialties (GPs: n = 1.299.641 prescriptions; gynecologists n = 141.8... by Thomas Hanslmeier (19949694)

    Published 2024
    Subjects: “…fluoroquinolone shares decreased…”
    Save to List
    Saved in:
  12. 1452
    Comparison of 1<sup>st</sup>, 2<sup>nd</sup>, and 3<sup>rd</sup> antibiotic prescription.

    Comparison of 1<sup>st</sup>, 2<sup>nd</sup>, and 3<sup>rd</sup> antibiotic prescription. by Thomas Hanslmeier (19949694)

    Published 2024
    Subjects: “…fluoroquinolone shares decreased…”
    Save to List
    Saved in:
  13. 1453
    UTI diagnoses by sex and physician specialty (2013–2019).

    UTI diagnoses by sex and physician specialty (2013–2019). by Thomas Hanslmeier (19949694)

    Published 2024
    Subjects: “…fluoroquinolone shares decreased…”
    Save to List
    Saved in:
  14. 1454
    Quality of life and Beck Depression Inventory baseline and post CRT+MRT, CRT and RUHB.

    Quality of life and Beck Depression Inventory baseline and post CRT+MRT, CRT and RUHB. by Sergio R. Thomaz (20308465)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  15. 1455
    Cardiorespiratory variable measurement of the study population.

    Cardiorespiratory variable measurement of the study population. by Sergio R. Thomaz (20308465)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  16. 1456
    Description of the myofascial release techniques.

    Description of the myofascial release techniques. by Sergio R. Thomaz (20308465)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  17. 1457
    ΔQuality of life and ΔBeck Depression Inventory baseline and post CRT+MRT, CRT and RUHB.

    ΔQuality of life and ΔBeck Depression Inventory baseline and post CRT+MRT, CRT and RUHB. by Sergio R. Thomaz (20308465)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  18. 1458
    Study flow diagram.

    Study flow diagram. by Sergio R. Thomaz (20308465)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  19. 1459
    Changes in maximal strength within each group after treatment.

    Changes in maximal strength within each group after treatment. by Sergio R. Thomaz (20308465)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  20. 1460
    ΔVO<sub>2</sub> (ml/min), ΔVO<sub>2</sub>/HR and ΔVE/VCO<sub>2</sub> slope baseline and post CRT+MRT, CRT and RUHB.

    ΔVO<sub>2</sub> (ml/min), ΔVO<sub>2</sub>/HR and ΔVE/VCO<sub>2</sub> slope baseline and post CRT+MRT, CRT and RUHB. by Sergio R. Thomaz (20308465)

    Published 2024
    Subjects:
    Save to List
    Saved in:

Search Tools: